Summary & Overview
CPT 86665: EBV VCA Antibody Immunoassay, Serum
CPT code 86665 denotes a laboratory immunoassay that detects antibodies to the viral capsid antigen (VCA) of Epstein–Barr virus (EBV) in patient serum. This serologic test is clinically significant for distinguishing acute from past EBV infection and informs diagnosis and patient management nationwide. Laboratories and payers use this code to classify and reimburse EBV VCA antibody testing.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, typical sites of service for performance and specimen collection, and the payer landscape included in the coverage review. The publication summarizes common billing practices, coding context, and benchmarking items relevant to laboratory services using this code.
The report provides clinical context for when CPT code 86665 is used, outlines what payers generally consider in coverage decisions, and presents benchmarking and policy updates relevant to laboratory immunoassay services. Data not available in the input will be noted where applicable.
Billing Code Overview
CPT code 86665 describes an immunoassay performed on serum to detect antibodies to the viral capsid antigen (VCA) of Epstein–Barr virus (EBV). The test evaluates a patient’s serologic response to EBV VCA and is used in clinical evaluation of suspected acute or past EBV infection.
-
Service type: Laboratory diagnostic immunoassay
-
Typical site of service: Clinical laboratory or hospital laboratory; specimen collection commonly occurs in an outpatient clinic or phlebotomy setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 19-year-old college student presents to an urgent care clinic with 5 days of fever, sore throat, fatigue, and cervical lymphadenopathy. The clinician performs a physical exam and orders laboratory testing to evaluate for infectious mononucleosis. A phlebotomy technician collects a serum sample which is sent to the hospital or reference laboratory. The laboratory analyst performs an immunoassay to detect antibodies to Epstein–Barr virus viral capsid antigen (VCA IgM and/or IgG) using automated immunoassay platforms. Results are reported to the ordering clinician, who uses the serology pattern (VCA IgM positive, VCA IgG positive/negative, and other EBV markers if available) to determine acute versus past EBV infection and to guide clinical counseling and follow-up. Typical sites of service include outpatient clinic, urgent care, emergency department, and independent/reference laboratories. The procedure is a laboratory diagnostic test performed by clinical laboratory personnel; specimen handling, accessioning, analysis, and result verification are part of the clinical workflow associated with this CPT-coded immunoassay.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the professional component of a test if separate reporting is allowed and the lab separates technical/professional components. |
TC | Technical component | Use when reporting only the technical component (laboratory processing, equipment, supplies) when the performing lab bills separately. |
91 | Repeat clinical diagnostic test | Use when the same test is repeated on the same day for verification or monitoring of an intervening clinical change. |
90 | Reference (outside) lab | Use when the specimen is forwarded to an outside or reference laboratory for analysis. |
QW | CLIA-waived test | Use only if the specific assay is CLIA-waived and performed under a waived CLIA certificate. |
59 | Distinct procedural service | Use when a separate, distinct lab procedure is performed same day and bundling rules might apply; use to indicate distinct service when appropriate. |
52 | Reduced services | Use when the lab service was partially reduced or not fully performed as described. |
53 | Discontinued procedure | Use when the test process was started but stopped for documented medical reasons. |
90 | Reference laboratory (duplicate entry for emphasis) | Use when outside laboratory performed the analysis; indicates outside lab provider relationship. |
91 | Repeat (duplicate entry for emphasis) | Use for repeated testing to obtain accurate results when clinically indicated. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207R00000X | Pathology & Laboratory Medicine | Clinical laboratory directors and pathologists overseeing testing and result interpretation. |
| 207L00000X | Clinical Cytogenetics (Laboratory) | Laboratory specialists who may run serologic/immunoassays in hospital labs (alternative lab taxonomy). |
| 208D00000X | Diagnostic Radiology (not typical) | Data not applicable; included only if ordering clinicians from diagnostic specialties request testing. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
B27.00 | Infectious mononucleosis due to Epstein-Barr virus without complications | Primary clinical indication for EBV VCA antibody testing to diagnose acute EBV infection. |
B27.01 | Infectious mononucleosis due to Epstein-Barr virus with other complications | Used when EBV infection presents with complications; serology aids diagnosis and management. |
R50.9 | Fever, unspecified | Non-specific fever prompting evaluation including EBV serology in appropriate clinical context. |
J02.9 | Acute pharyngitis, unspecified | Sore throat/pharyngitis is a common presentation leading to EBV testing when mononucleosis is suspected. |
R53.83 | Other fatigue | Persistent fatigue can prompt EBV serologic testing in diagnostic workup. |
K76.9 | Liver disease, unspecified | Abnormal liver function tests in suspected EBV cases may prompt EBV serology to evaluate viral hepatitis mimic. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
36415 | Collection of venous blood by venipuncture | Venipuncture is commonly performed prior to sending serum for the EBV VCA immunoassay. |
80053 | Comprehensive metabolic panel | Often ordered concurrently to assess liver function in patients with suspected infectious mononucleosis (elevated transaminases). |
86769 | Hepatitis C antibody; confirmatory immunoassay | Example of another serologic immunoassay workflow in the laboratory; similar processing and reporting steps. |
86664 | Cytomegalovirus (CMV) antibody serology; immunoassay for CMV IgM or IgG | CMV serologies are commonly ordered in the differential diagnosis of viral syndromes and can be run alongside EBV serology. |
86336 | Antibody; EBV nuclear antigen (EBNA) | EBNA testing is commonly used with VCA results to distinguish acute from past EBV infection; often ordered as part of the EBV serologic panel. |